IsoRay (ISR) Stock | When Will It Start Climbing Again?

IsoRay, Inc. (NASDAQ: ISR) IsoRay, has had an interesting week in the market thus far. After announcing that Cesium-131 was indeed effective in the treatment of cancer, the company went under attack by Adam Feuerstein; who discredited their press release and drove the stock price down. However, I’ve said a few times since then that … Read more

IsoRay (ISR) Bounces Back | Can It Last

IsoRay, Inc. (NYSEMKT: ISR) IsoRay had an interesting time in the market last week. After announcing that their Cesium-131 was as effective as current treatments; but with less time needed and less side effects, the company’s stock soared mid-week. However, the day following the press release, Adam Feuerstein attacked the company; driving the price down. … Read more

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR)

Sarepta Therapeutics (NASDAQ:SRPT) After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy … Read more

Opinion: “Adam Who?”

IsoRay, Inc. (NYSEMKT: ISR) This article was originally released on BioMedReports. However, I found it incredibly interesting. So, I thought I’d share. Considering the blatant attack Adam Feuerstein recently made against IsoRay and it’s Cesium-131 release, I thought it would be important to share a little bit about who Adam Feuerstein is and why ISR investors … Read more

IsoRay (ISR) Stock Looks To The Sky | Adam Feuerstein’s Big Miss!

IsoRay, Inc. (NYSEMKT: ISR) IsoRay is an incredible company that has proven to be innovative in the cancer treatment space. As a matter of fact, after releasing data with regard to the effectiveness of Cesium-131 last week, the company’s stock climbed. However, there seems to be one issue (blatantly unfounded issue I should say) that … Read more

IsoRay (ISR) Looks Great Regardless Of What Feuerstein Has To Say!

IsoRay, Inc. (NYSEMKT: ISR) This article was originally published at Warrior Trading News! IsoRay stock had an incredible day in the market after data was released regarding Cesium-131 on Wednesday. Unfortunately however, yesterday was a bit of a different story. Yesterday, the stock plummeted following a peer review of the data by Adam Feuerstein; and … Read more

IsoRay (ISR) Stock Looks Like It’s About To Climb…Again

IsoRay, Inc. (NYSEMKT: ISR) IsoRay has had a very interesting time in the market this week. After releasing positive data revolving around Cesium-131, the company’s stock skyrocketed; gaining more than 100% in a single day. However, yesterday Adam Feuerstein published a peer review that essentially stated that ISR released misleading data. As a result, the … Read more